• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Comprehensive analysis of pulmonary neuroendocrine carcinoma, Evaluation of pathologic classification and application for clinical diagnosis

Research Project

  • PDF
Project/Area Number 20590358
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionJapanese Foundation For Cancer Research

Principal Investigator

MOTOI Noriko  Japanese Foundation For Cancer Research, 癌研究所病理部, 研究員 (70292878)

Co-Investigator(Renkei-kenkyūsha) ISHIKAWA Yuichi  財団法人癌研究会, 癌研究所病理部, 部長 (80222975)
MATSUURA Masaaki  財団法人癌研究会, がんゲノム研究部, 部長 (40173794)
NAKAGAWA Ken  財団法人癌研究会, 癌研究所, 研究員 (60085595)
NISHIO Makoto  財団法人癌研究会, 癌研究所, 研究員 (00281593)
SHIMOJI Takashi  財団法人癌研究会, ゲノムセンター, 研究員 (40370150)
Project Period (FY) 2008 – 2010
Keywords肺癌 / 神経内分泌癌 / 小細胞癌 / 大細胞神経内分泌癌 / 網羅的発現解析 / 分子病理診断 / 遺伝子発現解析 / 免疫染色
Research Abstract

Background : The underlying oncogenic molecular alterations can influence the clinical features and phenotypes of lung cancer. Pulmonary neuroendocrine tumors include various histologic categories ; high grade neuroendocrine tumor (HGNET) (e.g. small cell carcinoma (SCLC) and large cell neuroendocrine carcinoma (LCNEC)), low grade NET (LGNET, e.g. typical and atypical carcinoid). It is still controversial whether non-small cell lung carcinoma (NSCLC) with neuroendocrine (NE) morphology or with NE phenotype should be included to NET or not. The goal of this study is to clarify the genetic and immunohistochemical profiling of pulmonary neuroendocrine tumors and to evaluate the clinicopathologic relevance of each tumor category, including NSCLC with NE features and with NE phenotypes, and to investigate new candidate for diagnosis and therapy.
Methods : Surgically resected lung cancers, including HGNET and LGNET, 5 NSCLC with NE-morphology (NS-NEm), NSCLC with NE-phenotype (NS-NEp), and NS … More CLC, were examined. Comprehensive gene expression analysis was done using Affymetrix U133A-plus2. Out of differentially expressed NE-related genes, expression levels of selected genes (ASCL1, CDH2, NeuroD1, etc.) were examined by quantitative realtime-PCR (qRTPCR) and by QuantiGene Assay (QG). Protein expressions of neuroendocrine markers were examined by immunohistochemistry (IHC) using tissue microarray (TMA) of formalin-fixed paraffin-embedded materials. Methylation status of ASCL1 promoter region in NET was also examined.
Results : Molecular profile revealed that HGNET and LGNET were differentially clustered. Among HGNET, SCLC and LCNEC showed similar mRNA expression profile of examined neuronal differentiation, cell proliferation and apoptosis related genes. LGNET showed different profile to both HGNET and NSCLC. NS-NEm and NS-NEp showed very low level of NE marker genes, but high level of KI67 and Survivin expressions. IHC expression levels of ASCL1 and KI67 (MIB1) were correlated well with mRNA expression levels of each gene. No difference of methylation status of ASLC1 gene in NET was revealed.
Conclusions : Both SCLC and LCNEC could be categorized as a high grade neuroendocrine tumor (HGNET) from a molecular stand point. In contrast, gene expression profile of SC-NEm and NS-NEp showed different from that of HGNET. ASCL1 could be used as neuronal differentiation markers for clinical differential diagnosis. On the methylation point of view, no difference was detected between NET and other lung cancer. Further examination will be needed to clarify the mechanism of neural gene expression in NET and criteria of NE differentiation marker for practical use. Less

  • Research Products

    (11 results)

All 2011 2010 2009 2008

All Journal Article (6 results) Presentation (5 results)

  • [Journal Article] 肺に発生する神経内分泌腫瘍2011

    • Author(s)
      元井紀子、石川雄一
    • Journal Title

      病理と臨床 29(5)

      Pages: 444-450

  • [Journal Article] Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations.2011

    • Author(s)
      Kudo K, Ohyanagi F, Horiike A, Motoi N, et al
    • Journal Title

      Lung Cancer. (Epub ahead of print)

  • [Journal Article] Identification of DOK genes as lung tumor suppressors.2010

    • Author(s)
      Berger AH, Niki M, Morotti A, Taylor BS, Socci ND, Motoi N, et al
    • Journal Title

      Nat Genet. 42(3)

      Pages: 216-23

  • [Journal Article] An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.2009

    • Author(s)
      Chitale D, Gong Y, Taylor BS, Broderick S, Brennan C, Motoi N, et al.
    • Journal Title

      Oncogene. 28

      Pages: 2773-83

  • [Journal Article] Lung adenocarcinoma : modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.2008

    • Author(s)
      Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, et al.
    • Journal Title

      Am J Surg Pathol. 32(6)

      Pages: 810-27

  • [Journal Article] Gene expression-based survival prediction in lung adenocarcinoma : a multi-site, blinded validation study.2008

    • Author(s)
      Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Motoi N, et al.
    • Journal Title

      Nat Med. 14(8)

      Pages: 822-7

  • [Presentation] 神経内分泌腫瘍の幹細胞性と細胞分化マーカーの発現(WS5 肺神経内分泌癌の基礎と臨床).2010

    • Author(s)
      元井紀子,長野裕子,濱中和嘉子,大場岳彦,小野宏,齋藤雄一,et al.
    • Organizer
      第51回日本肺癌学会
    • Place of Presentation
      広島国際会議場
    • Year and Date
      20101103-20101104
  • [Presentation] Neuroendocrine markers and ASCL1 expressions in various histologic types of systemic neuroendocrine tumors.2010

    • Author(s)
      元井紀子,濱中和嘉子,長野裕子,野村起美恵,大場岳彦,稲村健太郎,et al.
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場
    • Year and Date
      20100922-20100924
  • [Presentation] 神経内分泌腫瘍-特に非神経内分泌臓器における神経内分泌腫瘍-の系統的理解を目的として肺の神経内分泌腫瘍2010

    • Author(s)
      元井紀子
    • Organizer
      第99回日本病理学会総会
    • Place of Presentation
      東京、京王プラザホテル
    • Year and Date
      20100427-20100429
  • [Presentation] Genetic and immunohistochemical profile of pulmonary neuroendocrine tumor.2009

    • Author(s)
      Motoi N, Hamanaka W, Nagano H, Nomura K, Oba H, Inamura K, et al.
    • Organizer
      13th World Conference on Lung Cancer(Journal of Thoracic Oncology, 4 (9) Suppl.1 ; 2009. p.S484)
    • Place of Presentation
      San Francisco, CA, USA
    • Year and Date
      20090731-20090804
  • [Presentation] A subset of small cell lung cancer with low expression of neuroendocrine markers links to a good prognosis : a so far unrecognized subtype.2009

    • Author(s)
      Hamanaka W, Motoi N, Okumura S, Nakagawa K, Nishio M, Horai T, et al.
    • Organizer
      13th World Conference on Lung Cancer(Journal of Thoracic Oncology, 4 (9) Suppl.1 ; 2009.p.S466).
    • Place of Presentation
      San Francisco, CA, USA
    • Year and Date
      20090731-20090804

URL: 

Published: 2012-01-26   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi